Thr119

Site Information
AMBIGUOUS SITES: H2B (human): , H2B1A (human): , H2B1C (human): , H2B1D (human): , H2B1H (human): , H2B1K (human): , H2B1L (human): , H2B1M (human): , H2B1N (human): , H2B2E (human): , H2B2F (human): , H2BFH (human): , H2BU1 (human): , HIST1H2BJ (human):
sEGtkAVtkYtsAk_ SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 18010280

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 )
Disease tissue studied:	cervical cancer ( 2 ) , cervical adenocarcinoma ( 2 )
Relevant cell line - cell type - tissue:	HeLa S3 (cervical) ( 2 ) , Jurkat (T lymphocyte) ( 1 )

Upstream Regulation
Treatments:	nocodazole ( 2 )

References
1	Mertins P, et al. (2013) Integrated proteomic analysis of post-translational modifications by serial enrichment. Nat Methods 10, 634-7 23749302 Curated Info
2	Olsen JV, et al. (2010) Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal 3, ra3 20068231 Curated Info